← Back to directory

Tomas Olsson

Researcher Next ID · RN-023471

Researcher · Medicine

Karolinska University Hospital

Stockholm, Sweden

Not currently recruitingFunding unknown
Works count
1,003
Citation count
59,997
H-index
119
i10-index
646

Research interests

Medicine
Immunology and Microbiology
Multiple Sclerosis Research Studies
T-cell and B-cell Immunology
Immunotherapy and Immune Responses
Peripheral Neuropathies and Disorders
Systemic Lupus Erythematosus Research

Publications

  • Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease

    JAMA Neurology · 2021 · 10.1001/jamaneurol.2021.1858

  • Environmental and genetic risk factors for MS: an integrated review

    Annals of Clinical and Translational Neurology · 2019 · 10.1002/acn3.50862

  • Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology

    JAMA Neurology · 2019 · https://doi.org/10.1001/jamaneurol.2019.1534

  • Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

    JAMA Neurology · 2019 · 10.1001/jamaneurol.2019.3365

  • Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis

    Cell · 2018 · 10.1016/j.cell.2018.08.011

  • ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

    Multiple Sclerosis Journal · 2018 · https://doi.org/10.1177/1352458517751049

  • Overexpression of the Cytokine BAFF and Autoimmunity Risk

    New England Journal of Medicine · 2017 · 10.1056/nejmoa1610528

  • Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

    Neurology · 2017 · 10.1212/wnl.0000000000004683

  • Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis

    Nature Reviews Neurology · 2016 · https://doi.org/10.1038/nrneurol.2016.187

  • γ-secretase directly sheds the survival receptor BCMA from plasma cells

    Nature Communications · 2015 · 10.1038/ncomms8333

  • Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet Neurology · 2014 · 10.1016/s1474-4422(13)70308-9

  • Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial

    Multiple Sclerosis Journal · 2013 · 10.1177/1352458513507821

  • Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects

    PLoS Genetics · 2013 · 10.1371/journal.pgen.1003926

  • High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women

    Multiple Sclerosis Journal · 2012 · 10.1177/1352458512436596

  • Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

    New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1014656

  • Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

    Annals of Neurology · 2010 · 10.1002/ana.22247

  • Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice

    Autoimmunity Reviews · 2010 · 10.1016/j.autrev.2010.06.009

  • Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis

    Neurology · 2009 · 10.1212/wnl.0b013e3181b59c40

  • Neurofascin as a novel target for autoantibody-mediated axonal injury

    The Journal of Experimental Medicine · 2007 · 10.1084/jem.20071053

  • Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis

    Nature Genetics · 2007 · 10.1038/ng2106

  • MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

    Nature Genetics · 2005 · 10.1038/ng1544

  • Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis

    American Journal Of Pathology · 2000 · https://doi.org/10.1016/s0002-9440(10)64537-3

  • Autoimmunity to Myelin Oligodendrocyte Glycoprotein in Rats Mimics the Spectrum of Multiple Sclerosis Pathology

    Brain Pathology · 1998 · 10.1111/j.1750-3639.1998.tb00194.x

  • T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis

    The Journal of Immunology · 1991 · 10.4049/jimmunol.146.5.1490

  • Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.

    Journal of Clinical Investigation · 1990 · 10.1172/jci114800

Current projects

    No projects listed.